Dolutegravir Inhibits Autophagy In Vitro in a Mouse Blood-Brain Barrier Model. [PDF]
Huang C, Qu QR, Bendayan R.
europepmc +1 more source
Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i><sup><i>V600E</i></sup> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H. [PDF]
Salama AKS +18 more
europepmc +1 more source
Retraction: Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. [PDF]
Mihailidou C +3 more
europepmc +1 more source
Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study. [PDF]
Loosli T +22 more
europepmc +1 more source
Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case report. [PDF]
Li N, Hu J, Bao G, Cai Z.
europepmc +1 more source
Cabotegravir pharmacokinetics in Asians with and without HIV. [PDF]
Han K +9 more
europepmc +1 more source
Regioselective C3-C4 difunctionalization of 4-bromocoumarins <i>via</i> Pd/norbornene catalysis. [PDF]
Feyzi A, Jafarpour F.
europepmc +1 more source
New N-amino-5-cyano-6-pyridones as antimicrobial small molecules endowed with DNA gyrase a inhibitory activity: design, one-pot synthesis, biological assessment and in silico insights. [PDF]
Kamaly OA +5 more
europepmc +1 more source

